More than 6.5 million people across England are now waiting for routine NHS operations and treatments - from hip replacements to cataract surgery - as waiting lists reach a record-breaking 7.77 million pathways, new analysis reveals. This staggering figure means that roughly one in eight people in England are currently in the queue for elective care, representing the highest backlog in NHS history.
The data from The King's Fund, analysed up to September 2023, shows how the health service continues to wrestle with the lingering effects of the COVID-19 pandemic. Whilst the typical patient waits 15 weeks from GP referral to treatment starting - which may sound manageable - this average masks a more concerning reality for hundreds of thousands of people. More than 400,000 patients have been waiting over a year for their treatment, far longer than anyone should have to endure.
The NHS has a clear target: 92% of patients should begin their elective treatment within 18 weeks of referral. This standard hasn't been consistently achieved since February 2016, highlighting that waiting list pressures existed well before the pandemic struck. Currently, around 30% of patients are waiting longer than this 18-week benchmark - a significant gap that affects real people's daily lives, from managing pain to maintaining independence.
The scale of this challenge varies considerably across different medical specialties and regions of England, though no area remains unaffected. These lengthy queues create a cascade of pressure throughout the NHS system, straining hospital beds, theatre time, and already stretched staff - making it difficult to chip away at the backlog quickly.
NHS leaders and government officials recognise that tackling these waiting lists requires urgent action and sustained commitment. Current strategies include expanding diagnostic services, partnering with private healthcare providers, and redesigning patient care pathways to work more efficiently. However, given the sheer scale of the challenge, experts warn that returning to pre-pandemic performance levels and consistently meeting the 18-week target will require a comprehensive approach sustained over several years.